Diabetes Research and Clinical Practice
Volume 65, Issue 3 , Pages 227-234 , September 2004

Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease

  • Kenei Shimada

      Affiliations

    • Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-6-6645-3801; fax: +81-6-6645-3802.
    • ,
  • Takahiko Kawarabayashi

      Affiliations

    • Department of Cardiology, Baba Memorial Hospital, Sakai, Japan
    • ,
  • Atsushi Tanaka

      Affiliations

    • Department of Cardiology, Baba Memorial Hospital, Sakai, Japan
    • ,
  • Daiju Fukuda

      Affiliations

    • Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
    • ,
  • Yasuhiro Nakamura

      Affiliations

    • Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
    • ,
  • Minoru Yoshiyama

      Affiliations

    • Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
    • ,
  • Kazuhide Takeuchi

      Affiliations

    • Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
    • ,
  • Tetsuya Sawaki

      Affiliations

    • Suntory Research Center, Suntory Ltd., Osaka, Japan
    • ,
  • Kazuaki Hosoda

      Affiliations

    • Suntory Research Center, Suntory Ltd., Osaka, Japan
    • ,
  • Junichi Yoshikawa

      Affiliations

    • Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan

,Revised 15 January 2004 ,Accepted 21 January 2004.

References 

  1. Yang CS, Landau JM. Effects of tea consumption on nutrition and health. J. Nutr. 2000;130:2409–2412
  2. Benzie IF, Szeto YT. Total antioxidant capacity of teas by the ferric reducing/antioxidant power assay. J. Agric. Food Chem. 1999;47:633–636
  3. Yang TT, Koo MW. Hypercholesterolemic effects of Chinese tea. Pharmacol. Res. 1997;35:505–512
  4. Han LK, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of Oolong tea. Int. J. Obes. Relat. Metab. Disord. 1999;23:98–105
  5. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N.Y. Acad. Sci. 1999;892:146–154
  6. Hotta K, Funahashi T, Arita Y, et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000;20:1595–1599
  7. Ouchi N, Kihara S, Arita Y, et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473–2476
  8. Okamoto Y, Arita Y, Nishida M, et al.  An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm. Metab. Res. 2000;32:47–50
  9. Ouchi N, Kihara S, Arita Y, et al.  Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103:1057–1063
  10. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875–881
  11. Stampfer MJ, Krauss RM, Ma J, et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882–888
  12. Lamarche B, Tchernof A, Mauriege P, et al.  Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279:1955–1961
  13. Griffin BA, Freeman DJ, Tait GW, et al.  Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) sub-fractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241–253
  14. The Fifth Report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V), Arch. Intern. Med. 153 (1993) 154–183.
  15. Diabetes mellitus, Report of a WHO Study Group, World Health Organ. Tech. Rep. Ser. 727 (1985) 1–113.
  16. Xie B, Shi H, Chen Q, Ho CT. Antioxidant properties of fractions and polyphenol constituents from green, Oolong and black teas. Proc. Natl. Sci. Counc. 1993;17:77–84
  17. Arita Y, Kihara S, Ouchi N, et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999;257:79–83
  18. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917–1921
  19. Ouchi N, Kihara S, Arita Y, et al.  Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signalling through a cAMP-dependent pathway. Circulation. 2000;102:1296–1301
  20. Maeda N, Takahashi M, Funahashi T, et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50:2094–2099
  21. Okamoto Y, Kihara S, Ouchi N. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767–2770
  22. Vakkilainen J, Makimattila S, Seppala-Lindroos A. Endothelial dysfunction in men with small LDL particles. Circulation. 2000;102:716–721
  23. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 1993;94:350–356
  24. Galeano NF, Milne R, Marcel YL, et al.  Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J. Biol. Chem. 1994;269:511–519
  25. Chen GC, Liu W, Duchateau P, et al.  Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. J. Biol. Chem. 1994;269:2912–2918
  26. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis. 1996;124:261–271
  27. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506
  28. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J. Clin. Invest. 1993;92:141–146
  29. Maeda N, Shimomura I, Kishida K, et al.  Diet-induced insulin resistance in mice locking adiponectin/ACRP30. Nat. Med. 2002;8:731–737
  30. Hotta K, Funahashi T, Bodkin NL, et al.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126–1133
  31. Rumpler W, Seale J, Clevidence B. Oolong tea increases metabolic rate and fat oxidation in men. J. Nutr. 2001;131:2848–2852
  32. Miyazaki C, Takeuchi M, Yoshitani H, et al.  Optimum hypoglycemic therapy can improve coronary flow velocity reserve in diabetic patients-demonstration by transthoracic Doppler echocardiography. Circ. J. 2003;67:945–950

PII: S0168-8227(04)00021-X

doi: 10.1016/j.diabres.2004.01.003

Diabetes Research and Clinical Practice
Volume 65, Issue 3 , Pages 227-234 , September 2004

Article Tools

* Image Usage & Resolution